We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Serum Albumin Levels Predict Pneumonia Severity

By LabMedica International staff writers
Posted on 30 Jan 2013
The prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia has been evaluated. More...


When serum albumin levels are measured within 24 hours of admission to the hospital, they can be correlated with the outcome of patients with community-acquired pneumonia (CAP).

Scientists at the University Hospital of Bellvitge (Barcelona, Spain) carried out a prospective cohort of adults with CAP requiring hospitalization from 1995 through 2011. Serum albumin results were obtained from the central laboratory database and were determined by a molecular absorption spectrometry utilizing bromocresol green. Pathogens in blood, normally sterile fluids, sputum, and other samples were investigated using standard microbiological procedures. Serum albumin levels were measured within 24 hours of admission. The primary end point was 30-day mortality.

During the study period, 3,463 patients with CAP required hospitalization. The median value of albumin was 31 g/L. As levels of serum albumin decrease, the risk of complications significantly increased. Decreased albumin levels were also significantly associated with prolonged time to reach clinical stability, prolonged hospital stay, intensive care unit (ICU) admission, the need for mechanical ventilation, and 30-day mortality. Hypoalbuminemia was documented in 1,307 (37.7%) patients, whose serum albumin was less than 30 g/L.

The authors concluded that hypoalbuminemia is frequent among hospitalized patients with CAP. Low serum albumin levels within 24 hours of hospital admission are significantly associated with increased risk of complications and poor outcome from CAP. Serum albumin is an objective and good prognostic marker in hospitalized adults with CAP. The study was published on December 31, 2012, in the Journal of Infection.

Related Links:

University Hospital of Bellvitge




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.